We are monitoring the impact of COVID-19 on Cancer/Tumor Profiling Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 8736
Share on
Share on

Global Cancer/Tumor Profiling Market Analysis – By Technology, Technique, Application, By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) - Industry Size, Share, Trends, Growth, Forecast | 2019 - 2024

Pulished: February, 2020
ID: 8736
Pages: 250

Cancer/Tumor Profiling Market Size & Growth (2019 - 2024)

Globally, the size of the Cancer/Tumor Profiling Market estimated to reach USD 82.4 Billion by 2024 registering a CAGR of more than 18% from 2019 to 2024.

Increasing incidences of different types of cancer diseases are major factors propelling the demand of the market. Cancer tumor profiling evaluates the properties and metabolism of the cells and also understands the molecular level while diagnosing and this is ascribed to bolster the demand of the market to the extent. Growing prevalence to have effective treatment procedures is driving the growth of the market. The rise in the geriatric population is also one more factor accelerating the growth of the Cancer/Tumor Profiling Market.

However, the cost for installation of the equipment is very high and this is quietly restraining the demand of the market. Lack of skilled physicians in making accurate decisions through reports is impeding the growth of the market. Also, the devices need regular inspection as there is a chance for failure in real-time applications where staff-members negligence in maintaining the devices is slowly restraining the demand of the Cancer/Tumor Profiling Market.

The rise in living standards is also boosting up the growth of the market. Growth opportunities for the market lie in the increasing demand for targeted therapies where the patient has a prominent response to the therapy. In addition, growing prevalence to have effective treatment procedures at any cost is leveling up the demand of the market. Increasing the use of biomarkers for treating cancer is escalating the growth rate of cancer/tumor profiling market. Adoption of a sedentary lifestyle and changes in the food habits is also considered to be an attribute influencing the demand of the Cancer/Tumor Profiling Market.

Key happenings in this market in the recent past:

  • HTG Molecular Technologies, Inc. has developed a product for tumor profiling called Edge Seq mouse mRNA tumor response panel. The significant applications of this product are analysis of immune response to xenografts, detailed investigational research of therapeutics, and oncogenesis modeling. This tumor response panel enables the profiling of various types of samples, such as extracted RNA samples, FFPE tissue, and cell lines.
  • Caris has completed the deal to acquire Phamatech, Inc., in May 2019. With the acquisition of this company, the Caris has expanded its share with the inclusion of oncology network, and other clinical trials for precision oncology.
  • QIAGEN NV Company has developed a diagnostic kit called therascreen PIK3CA in May 2019. The objective of this kit is to detect breast cancer in patients.
  • Sysmex Corporation has expanded its business in the UK by inaugurating a new operations unit in February 2019. The new facility in Cambridge will handle the operations of the company’s fish probe and Cytocell brands. 
  • In May 2019, QIAGEN Company collaborated with other UK-originated organizations to launch APIS Assay Technologies Ltd., the primary objectives of the company is to focus on enhancing the biomarker products and achieve a better success rate of biomarker commercialization.




Market Size Available

2018 – 2024

Base Year


Forecast Period

2019 - 2024

Segments Covered

By Technique, Technique, Application, Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

Illumina, Inc. (US), QIAGEN N.V. (Germany), NeoGenomics Laboratories, Inc. (U.S.), HTG Molecular Diagnostics, Inc. (U.S.), Genomic Health Inc. (U.S.), Caris Life Sciences (U.S.), Helomics Corporation (U.S.), NanoString Technologies, Inc. (U.S.), Sysmex Corporation (Japan), RiboMed Biotechnologies, Inc. (U.S.), Guardant Health, Inc. (U.S.), and Foundation Medicine (U.S.)


This market research report on Global Cancer/Tumor Profiling Market has been segmented and sub-segmented into the following categories and analyzed market size and forecast until 2024.

Cancer/Tumor Profiling Market Analysis - By Technology

On the basis of technology, the Next-generation sequencing technology segment is witnessed in leading the highest shares of the market. Rise in the support from the government and changing schemes in favor of the common people is leveraging the growth rate of the Cancer/Tumor Profiling Market.  

Cancer/Tumor Profiling Market Analysis - By Technique

On the basis of technique, the Genomics technique segment is leading with the highest shares of the market. Increasing demand for personalized medications is outshining the growth of the market. Furthermore, the rise in disposable income in urban areas is making the market share to expand enormously.

Cancer/Tumor Profiling Market Analysis - By Application

  • Personalized Medicine
  • Diagnostics
  • Biomarker Discovery
  • Prognostics
  • Research Applications

On the basis of application, the personalized medicine application is ruling with the highest shares of the market. Rise in the scale of research institutes and also demand to promote the wellbeing of humans after cancer therapies are fueling the demand of the market.

Cancer/Tumor Profiling Market Analysis - By Region

  • North America (U.S., Canada)
  • Europe (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of EU)
  • Asia Pacific (India, China, Japan, South Korea, Australia & New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC
  • Latin America (Brazil, Mexico, Argentina, Chile)
  • Middle East and Africa (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA)

North America is witnessed in dominating the highest shares of the market by owing to the rise in the capital income in developed and developing countries. Also, the availability of skilled persons in performing effective targeted surgeries for cancer is broadening the demand of the market. Europe and the Asia Pacific are holding the largest shares of the Global Cancer/Tumor Profiling Market with the increasing elderly population. Additionally, the launch of the reimbursement scheme by the government in concern towards people’s health is surging the demand of the market. The Middle East and Africa are projected to have inclined growth rates in coming years with the rise in awareness towards treatment procedures and also the implementation of various techniques in diagnostics centers.

List of most promising companies in the Global Cancer/Tumor Profiling Market profiled in this report are:

  1. Illumina, Inc. (US)
  2. QIAGEN N.V. (Germany)
  3. NeoGenomics Laboratories, Inc. (US)
  4. HTG Molecular Diagnostics, Inc. (US)
  5. Genomic Health Inc. (US)
  6. Caris Life Sciences (US)
  7. Helomics Corporation (US)
  8. NanoString Technologies, Inc. (US)
  9. Sysmex Corporation (Japan)
  10. RiboMed Biotechnologies, Inc. (US)
  11. Guardant Health, Inc. (US)
  12. Foundation Medicine (US)
  1. Introduction
    1. Market Definition                                    
    2. Study Deliverables                                  
    3. Base Currency, Base Year and Forecast Periods                                          
    4. General Study Assumptions                                
  2. Research Methodology
    1. Introduction                                               
    2. Analysis Design                                         
    3. Research Phases                                      
      1. Secondary Research                           
      2. Primary Research                 
      3. Econometric Modelling                      
      4. Expert Validation                  
    4. Study Timeline                                          
  3. Overview
    1. Executive Summary                                
    2. Key Inferences                                         
    3. New Developments                                               
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers                                          
    2. Market Restraints                                    
    3. Key Challenges                                         
    4. Current Opportunities in the Market                                              
  5. Market Segmentation
    1. Global Cancer/Tumor Profiling Market, By Technology
      1. Next-generation Sequencing (NGS)
      2. Polymerase Chain Reaction (PCR)
      3. Immunohistochemistry (IHC)
      4. In Situ Hybridization (ISH)
        1. Fluorescence In Situ Hybridization (FISH)
        2. Chromogenic In Situ Hybridization (CISH)
      5. Microarray
      6. Others
    2. Global Cancer/Tumor Profiling Market, By Technique
      1. Genomics
      2. Proteomics
      3. Epigenetics
      4. Metabolomics
    3. Global Cancer/Tumor Profiling Market, By Application
      1. Personalized Medicine
      2. Diagnostics
      3. Biomarker Discovery
      4. Prognostics
      5. Research Applications
  6. Geographical Analysis
    1. North America                                          
      1. Introduction                           
      2. United States                         
      3. Canada                     
    2. Europe                                         
      1. Introduction                           
      2. U.K                             
      3. Spain                         
      4. Germany                 
      5. Italy                            
      6. France                       
    3. Asia-Pacific                                 
      1. Introduction                           
      2. China                         
      3. India                          
      4. Japan                         
      5. South Korea                           
    4. Latin America                                             
      1. Introduction                           
      2. Brazil                          
      3. Argentina                
      4. Mexico                     
    5. Middle East & Africa 
      1. Introduction
      2. Middle-East
      3. Africa                                              
  7. Strategic Analysis
    1. PESTLE analysis                                         
      1. Political                     
      2. Economic                 
      3. Social                         
      4. Technological                         
      5. Legal                          
      6. Environmental                       
    2. Porter’s Five analysis                                              
      1. Bargaining Power of Suppliers                        
      2. Bargaining Power of Consumers                    
      3. Threat of New Entrants                     
      4. Threat of Substitute Products and Services                              
      5. Competitive Rivalry within the Industry                     
  8. Market Leaders' Analysis
    1. Illumina, Inc. (US)
      1. Overview                 
      2. Product Analysis                   
      3. Strategic Evaluation and Operations                            
      4. Financial analysis                  
      5. Legal issues                             
      6. Recent Developments                       
      7. SWOT analysis                       
      8. Analyst View                          
    2. QIAGEN N.V. (Germany)
    3. NeoGenomics Laboratories, Inc. (US)
    4. HTG Molecular Diagnostics, Inc. (US)
    5. Genomic Health Inc. (US)
    6. Caris Life Sciences (US)
    7. Helomics Corporation (US)
    8. NanoString Technologies, Inc. (US)
    9. Sysmex Corporation (Japan)
    10. RiboMed Biotechnologies, Inc. (US)
    11. Guardant Health, Inc. (US)
    12. Foundation Medicine (US)
  9. Competitive Landscape
    1. Market share analysis                                            
    2. Merger and Acquisition Analysis                                       
    3. Agreements, collaborations and Joint Ventures                                         
    4. New Product Launches                                         
  10. Expert Opinions
    1. Market Outlook                                     
    2. Investment Opportunities                                 
  11. Appendix                                                           
  12. List of Tables
  13. List of Figures
  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

Avail Sample to get the list of tables and figures.

Please wait. . . . Your request is being processed


$ 1234 4255

Click for Request Sample